646jili

Your Location: Home>60 jilibet

646jili: Published: 2025-01-12Source: 646jili

Summary Tips: 646jili is referred to as China News Service Guangxi Channel and China News Service Guangxi Network, which is the first news website established by the central media in Guangxi. ph646 jilibet Overall positioning: a comprehensive news website with external propaganda characteristics, the largest external communication platform in Guangxi. 646jili1 com Provide services for industry enterprises, welcome to visit 646jili !

646jili 。ph646 jilibet photograph

AUSTIN, Texas, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, "Molecular Templates,” or "MTEM” or the "Company”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, known as engineered toxin bodies, to create novel therapies with potent and differentiated mechanisms of action for cancer, was notified on December 16, 2024 by the Listing Qualifications Department (the "Staff”) of The Nasdaq Stock Market LLC ("Nasdaq”) of the Staff's determination pursuant to Nasdaq Listing Rule 5101 that the Company is a "public shell,” and that, in the view of the Staff, the continued listing of the Company's securities was no longer warranted. Further, Nasdaq indicated that the Company's non-compliance with (i) Nasdaq Listing Rule 5250(c)(1) as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the period ended September 30, 2024 and (ii) Nasdaq Listing Rule 5550(a)(2) as a result of its failure to maintain a $1.00 bid price for the required period, each serving as an additional and separate basis for delisting. Trading of the Company's common stock will be suspended at the opening of business on December 26, 2024, and Nasdaq will file a Form 25-NSE with the U.S. Securities and Exchange Commission to formally delist the Company's securities from listing and registration, unless the Company timely requests a hearing before a Nasdaq Hearings Panel to appeal Nasdaq's determination and address the deficiencies. The Company does not plan to request a hearing regarding these deficiencies and expects that trading in the Company's common stock on the Nasdaq Stock Market will be suspended upon the opening of business on December 26, 2024. About Molecular Templates Molecular Templates is a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation ADCs. Its drug platform technology, known as Engineered Toxin Bodies (ETBs), leverages the resident biology of a genetically engineered toxin payload to create novel therapies with potent and differentiated mechanisms of action for cancer and various disease indications. Cautionary Information Regarding Trading in the Company's Securities The Company cautions that trading in the Company's securities is highly speculative and poses substantial risks. Trading prices for the Company's securities likely bear little or no relationship to the actual value realized, if any, by holders of the Company's securities. The Company currently has extremely limited resources to continue or wind down operations. Accordingly, the Company urges extreme caution with respect to existing and future investments in its securities. Forward-Looking Statements This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act”). Molecular Templates disclaims any intent or obligation to update these forward-looking statements and claims the protection of the Act's Safe Harbor for forward-looking statements. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations, future financial position, prospects and plans and objectives of management are forward-looking statements. In addition, when or if used in this press release, the words "may,” "could,” "should,” "anticipate,” "believe,” "estimate,” "expect,” "intend,” "plan,” "predict” and similar expressions and their variants, as they relate to Molecular Templates may identify forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties. Actual events or results may differ materially from those discussed in the forward-looking statements as a result of various factors including, but not limited to the following: the continued availability of financing on commercially reasonable terms of which there can be no assurance that any financing will be obtained; whether Molecular Templates' cash resources will be sufficient to fund any future operations or winddown activities; the results of MTEM's clinical studies which are currently unable to resume due to lack of resources; the ability to effectively operate MTEM and retain key employees and consultants post-MTEM's previously announced restructuring and reductions in force; the ability of MTEM to resume its regular and required Exchange Act reporting obligations which the Company is currently unable to do; and those risks identified under the heading "Risk Factors” in Molecular Templates' filings with the SEC, including its most recently filed Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 and any subsequently filed reports. Any forward-looking statements contained in this press release speak only as of the date hereof, and Molecular Templates specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise. CONTACT: Contact Michelle Iwamoto-Fan [email protected]646jili 。

Title: Community Responds to 19-Year-Old Brother Dropping Out of School to Work and Care for Sister - Siblings Receive Support for a Carefree LifeHow you can giveTORONTO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Onex Corporation (the “ Company ”) (TSX: ONEX) announced today that, in connection with the Company’s ongoing substantial issuer bid (the “ Offer ”), the Company has obtained an order from the Ontario Securities Commission granting exemptive relief from certain extension, proportionate take-up and related disclosure requirements in connection with the Offer, the details of which can be found in the offer to purchase and issuer bid circular filed by the Company in connection with the Offer (the “ Circular ”), which is available on SEDAR+ at www.sedarplus.ca . Details of the Offer, including instructions for tendering subordinate voting shares of the Company (the “ Subordinate Voting Shares ”), are included in the Circular, letter of transmittal and the notice of guaranteed delivery (collectively, the “ Offer Documents ”). The Offer Documents are available on SEDAR+ at www.sedarplus.ca , as well as on the Company's website at www.onex.com . Shareholders should carefully read the Offer Documents prior to making a decision with respect to the Offer. This press release is for informational purposes only and does not constitute an offer to buy or the solicitation of an offer to sell the Subordinate Voting Shares. The solicitation and the offer to buy the Subordinate Voting Shares will only be made pursuant to the Offer Documents. ABOUT ONEX Onex invests and manages capital on behalf of its shareholders and clients across the globe. Formed in 1984, we have a long track record of creating value for our clients and shareholders. Our investors include a broad range of global clients, including public and private pension plans, sovereign wealth funds, insurance companies, family offices and high-net-worth individuals. In total, Onex has approximately $50 billion in assets under management, of which $8.5 billion is Onex’ own investing capital. With offices in Toronto, New York, New Jersey and London, Onex and its experienced management teams are collectively the largest investors across Onex’ platforms. Onex is listed on the Toronto Stock Exchange under the symbol ONEX. For more information on Onex, visit its website at www.onex.com . Onex’ security filings can also be accessed at www.sedarplus.ca . CAUTION REGARDING FORWARD LOOKING STATEMENTS This press release may contain, without limitation, statements concerning possible or assumed future operations, performance or results preceded by, followed by or that include words such as “believes”, “expects”, “potential”, “anticipates”, “estimates”, “intends”, “plans” and words of similar connotation, which would constitute forward-looking statements. Forward-looking statements are not guarantees. The reader should not place undue reliance on forward-looking statements and information because they involve significant and diverse risks and uncertainties that may cause actual operations, performance or results to be materially different from those indicated in these forward-looking statements. Except as may be required by Canadian securities law, Onex is under no obligation to update any forward-looking statements contained herein should material facts change due to new information, future events or other factors. These cautionary statements expressly qualify all forward-looking statements in this press release. FOR FURTHER INFORMATION:

PHILADELPHIA , Dec. 19, 2024 /PRNewswire/ -- FMC Corporation (NYSE: FMC) announced today it will release its fourth quarter 2024 earnings on Tuesday, February 4, 2025 , after the stock market close via PR Newswire and the company's website https://investors.fmc.com . The company will host a webcast conference call on Tuesday, February 4, 2025 , at 5:00 p.m. ET that is open to the public via internet broadcast and telephone. At this time, management will provide commentary on the results from the fourth quarter and full year 2024, guidance for the first quarter and full year 2025, as well as an update on the three-year outlook and the company's strategy. The call time has been extended to 90 minutes from the usual 60 minutes to accommodate the number of topics and Q&A adequately. Conference Call Details: Internet broadcast: https://investors.fmc.com United States (Local): +1 404 975 4839 United States ( Toll-Free ): +1 833 470 1428 Global Dial-In Numbers: Global Dial-in Number Access Code: 338624 Pre-Registration Link: https://www.netroadshow.com/events/login?show=2f7e0221&confId=75596 A replay of the call will be available via the internet and telephone from 6:30 p.m. ET on February 4, 2025 , until February 24, 2025 . Internet replay: https://investors.fmc.com United States (Local): 1 929 458 6194 United States ( Toll-Free ): 1 866 813 9403 Access Code: 793208 About FMC FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC's innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers and crop advisers to address their toughest challenges economically while protecting the environment. With approximately 5,800 employees at more than 100 sites worldwide, FMC is committed to discovering new herbicide, insecticide and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet. Visit fmc.com to learn more and follow us on LinkedIn ® . View original content to download multimedia: https://www.prnewswire.com/news-releases/fmc-corporation-announces-date-for-fourth-quarter-2024-earnings-release-and-webcast-conference-call-302336288.html SOURCE FMC Corporation

Betel nuts, also known as areca nuts, are a popular psychoactive substance in many Asian countries, often chewed for their stimulant effects. Despite being culturally ingrained in some societies, the long-term consumption of betel nuts can have serious health implications, both physically and mentally.As the news continued to gain momentum, the Tianjin Municipal Education Commission felt compelled to address the misinformation and prevent any further confusion. They urged the public to verify information from reliable sources and refrain from spreading unverified news that could potentially mislead others.WASHINGTON — After decades of inaction, federal transportation officials have moved ahead with requiring new technologies to reduce crashes and fatalities involving large trucks. But the incoming administration could install a red light to block their efforts. At issue are proposed new rules by the Federal Motor Carrier Safety Administration and the National Highway Traffic Safety Administration to require large trucks to be equipped with automatic emergency braking systems and devices to limit their speeds. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

Latest News

Hot Recommendations

Reading Ranking

Hot pictures